This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Acute Pyelonephritis Treatment Market

Acute Pyelonephritis Treatment Market

Acute Pyelonephritis Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2018 to 2028

Acute Pyelonephritis Treatment Market
FACT1764MR

Introduction

Acute pyelonephritis is a disease that occurs due to severe kidney infection. The infection starts through the lower urinary tract infection (UTI) and spreads through the urethra, where the bacteria multiplies. The bacteria travels through the ureters and reaches the kidney. Moreover, the bacteria can reach the kidney through the blood stream. The disease occurs mostly in women due to shorter urethra as compared to men. Acute pyelonephritis is caused due to bacteria such as E.coli, Enterobactor, Pseudomonas and many more. Acute pyelonephritis is diagnosed with urine tests, imaging and radioactive imaging. The urine tests would check for the bacteria, pus cells and concentration while imaging tests such as ultrasound will diagnose the obstructions in the urinary tracts. The patient may have a significant impact if the disease is not treated on time. The disease spreads and establishes itself very quickly with bladder inflammation, chills, fever, urinary frequency and urgency. Acute pyelonephritis is treated with broad spectrum antibiotics such as levofloxacin, ciprofloxacin and ampicillin. However, in severe cases the drugs are ineffective and the patient has to be hospitalized. Moreover, due to the increased levels of progesterone and increased pressure on the uterus, pregnant women are also prone to acute pyelonephritis. Acute pyelonephritis can be prevented by drinking plenty of water, which will remove the bacteria from the body in the form of urine.

Acute Pyelonephritis Treatment Market: Drivers and Restraints

The growing prevalence of chronic kidney associated diseases such as kidney stones, bladder conditions are expected to be the major factor driving the growth of the acute pyelonephritis treatment market over the forecast period. According to Centers for Disease Control and Prevention (CDC), 15% (30 million) people suffer from chronic kidney disease in the U.S. The prevalence of acute pyelonephritis has increased due to change in the lifestyle and eating habits, alcohol consumption and smoking. Addition of new generics and drugs with increase in the treatment seeking rate is the other factor contributing to the growth of the global pyelonephritis treatment market. The overall market acute pyelonephritis treatment is pushed by the increasing demand for growing expenditure and investment on healthcare by the government

Know More Details About the Report

Acute Pyelonephritis Treatment Market: Overview

The global market for acute pyelonephritis treatment is expected to witness a high growth over the forecast period. Majority of the drugs are introduced in the generic market and thus there exists a high competition among local and regional players. Acute pyelonephritis is a life threatening metabolic disease which is caused due to urinary tract infection. The first course of treatment of acute pyelonephritis is antibiotics. The drugs are divided based on the route of administration and the distribution channel. Moreover, they are diagnosed with various blood tests, urine culture tests, MRI, dimercaptosuccinic acid (DMSA) tests. The market for the treatment of acute pyelonephritis is expected to increase with the rise in the patient pool opting for drugs.

Acute Pyelonephritis Treatment Market: Regional Outlook

Geographically, the global acute pyelonephritis treatment market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be dominant market in the global acute pyelonephritis treatment market owing to high prevalence of the diseases. Also the market in North America will rise due to the advancement in the technology, strict regulations for patient care and safety in the region. The acute pyelonephritis treatment market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to expansion of product offerings by the key players. In addition, initiatives by the governments in the region on providing better healthcare facilities and effective diagnosis of the disease will contribute to the growth of acute pyelonephritis treatment. Europe is expected to have second large share in the global acute pyelonephritis treatment Market throughout the forecast period.

Avail customized purchase options for your needs

Acute Pyelonephritis Treatment Market: Key Players

The global market for acute pyelonephritis treatment is highly fragmented. Examples of some of the key players operating in the global acute pyelonephritis treatment are Indica Laboratories Pvt Ltd, Biochem Pharmaceutical Industries Ltd, Cadila Healthcare, Pfizer Inc., Merck & Co., Inc. , Bristol Laboratories Ltd, Uquifa and Bristol-Myers Squibb, among others.

This analytical research study imparts an all-inclusive assessment on the market, while propounding historical intelligence, actionable insights, and industry-validated & statistically-upheld market forecast. Verified and suitable set of assumptions and methodology has been leveraged for developing this comprehensive study. Information and analysis on key market segments incorporated in the report has been delivered in weighted chapters. A thorough analysis has been offered by the report on

  • Market Dynamics
  • Market Size
  • Market Segments
  • Demand & Supply Trends
  • Current Issues and Challenges
  • Companies and Competitor Landscape
  • Value Chain
  • Technology

Regional Segments Analyzed Include

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa)

Compilation of authentic and first-hand intelligence, insights offered in the report are based on quantitative and qualitative assessment by leading industry experts, and inputs from opinion leaders & industry participants around the value chain. Growth determinants, macroeconomic indicators, and parent market trends have been scrutinized and delivered, coupled with the market attractiveness for each market segment encompassed. Qualitative impact of growth influencers on the market segments across regions has also been mapped by the report.

An Adaptive Approach to Modern-day Research Needs

Highlights from the Report

  • Elaborated scenario of the parent market
  • Transformations in the market dynamics
  • Detailed segmentation of the target market
  • Historical, current and forecast market size based on value and volume
  • Latest industry developments and trends
  • Competition landscape
  • Strategies adopted by the market players and product developments made
  • Potential and niche segments, along with their regional analysis
  • Unbiased analysis on performance of the market
  • Up-to-date and must-have intelligence for the market players to enhance and sustain their competitiveness

Acute Pyelonephritis Treatment Market: Segmentation

Tentatively, the global acute pyelonephritis treatment market can be segmented on the basis of route of administration, distribution channel, and geography.

Based on route of administration, the global acute pyelonephritis treatment market is segmented as:

  • Oral
  • Injectable

Based on distribution channel, the global acute pyelonephritis treatment market is segmented as:

  • Hospital Pharmacy
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacy

Based on geography, the global acute pyelonephritis treatment market is segmented as:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East and Africa

Need an Exclusive Report for your Unique Requirement?

Talk Show:

The Rise of Intelligent Packaging

Personalized, Connected and Sustainable

November 18, 2021 11:00-11:45 AM PST (USA & Canada)
This is a LIVE session
Future Market Insights MarketNgage Spring

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.